Get all your news in one place.
100’s of premium titles.
One app.
Start reading
The New Zealand Herald
The New Zealand Herald
National

Covid-19 Omicron outbreak: Novavax vaccine approved for use in New Zealand

By RNZ

The Novavax Covid-19 vaccine has been approved in New Zealand for those aged 18 and over.

The first doses are expected to arrive this month.

The Novavax vaccine Nuvaxovid is the fourth vaccine to be approved by Medsafe.

Vials with the Nuvaxovid vaccine against the Covid-19 coronavirus are seen at the CIZ Tegel vaccination center in Berlin. Photo / Getty Images

Pfizer/BioNTech, AstraZeneca and Janssen are all approved for use in New Zealand.

Nuvaxovid is a two-dose protein subunit vaccine.

- RNZ

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
From analysis to the latest developments in health, read the most diverse news in one place.
Already a member? Sign in here
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.